Tom van Blarcom

Chief Tech/Sci/R&D Officer at KYVERNA THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Tom van Blarcom is currently the Senior Vice President & Head-Research at Kyverna Therapeutics, Inc. He previously worked as the Senior Director-Medical at Genentech, Inc., the Executive Director & Head-Protein Engineering at Allogene Therapeutics, Inc., and the Vice President at Horizon Therapeutics, Inc. Dr. van Blarcom completed his undergraduate studies at Universite Paris Est.
Creteil Val De Marne and North Carolina State University.
He holds a doctorate degree from The University of Texas at Austin.

Tom van Blarcom active positions

Companies	Position	Start
KYVERNA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

All active positions of Tom van Blarcom

Former positions of Tom van Blarcom

Companies	Position	End
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Chief Tech/Sci/R&D Officer	-
ALLOGENE THERAPEUTICS, INC.	Director/Board Member	-
Horizon Therapeutics, Inc. Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.	Corporate Officer/Principal	-

See the detail of Tom van Blarcom's experience

Training of Tom van Blarcom

Universite Paris Est Creteil Val De Marne	Undergraduate Degree
The University of Texas at Austin	Doctorate Degree
North Carolina State University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tom van Blarcom's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
KYVERNA THERAPEUTICS, INC.	Health Technology
ALLOGENE THERAPEUTICS, INC.	Health Technology

Private companies	2
Horizon Therapeutics, Inc. Horizon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology